CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net loss	$ (152,149)	$ (144,326)	$ (78,994)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	41,168	26,756	10,949
Stock-based compensation	40,556	36,450	17,659
Amortization of debt discount and debt issuance costs	2,038	1,868	3,974
Amortization of right-of-use assets	2,760	3,418	683
Write-down for excess and obsolete inventories	9,792	11,147	7,044
Loss on disposal of assets	2,594	1,976	498
Loss on debt extinguishment, net		7,434	7,612
Impairment of investment		3,000
Other	1,187	2,721	116
Changes in operating assets and liabilities:
Accounts receivable	(18,832)	(10,141)	(7,484)
Inventories	(20,704)	(27,746)	(18,192)
Prepaid expenses and other current assets	552	1,258	(2,930)
Other assets	(109)	11	(51)
Accounts payable	9,796	757	7,130
Accrued expenses and other current liabilities	13,508	8,023	8,812
Lease liability	(2,678)	150	(1,312)
Contract liabilities	(2,280)	(1,040)
Other long-term liabilities	(2,342)	4,852	(1,926)
Net cash used in operating activities	(75,143)	(73,432)	(46,412)
Investing activities:
Purchases of property and equipment	(49,453)	(68,544)	(23,131)
Purchase of intangible assets	(8,827)		(755)
Acquisition of business, net of cash acquired		(62,133)
Purchase of OCEANE		(21,097)
Cash paid for investments		(3,000)
Settlement of forward contract		(2,988)
Cash received from sale of assets			27
Net cash used in investing activities	(58,280)	(157,762)	(23,859)
Financing activities:
Proceeds from Revolving Credit Facility and line of credit	62,500		42,455
Payment of debt issuance costs	(1,315)	(10,028)
Proceeds from common stock offering		131,828	107,698
Proceeds from issuance of convertible notes		316,250
Net cash (paid) received from common stock exercises	(3,041)	(5,963)	3,341
Purchase of capped calls		(39,866)
Repurchase of common stock		(25,000)
Proceeds from term debt			34,008
Repayment of Revolving Credit Facility and line of credit	(27,500)		(56,615)
Repayment of Squadron Medical Term Loan		(45,000)
Repayment of Inventory Financing Agreement		(8,088)
Other	584	(2,167)	(58)
Net cash provided by financing activities	31,228	311,966	130,829
Effect of exchange rate changes on cash	(357)	(1,289)	94
Net change in cash and cash equivalents	(102,552)	79,483	60,652
Cash and cash equivalents at beginning of year	187,248	107,765	47,113
Cash and cash equivalents at end of year	84,696	187,248	107,765
Supplemental disclosure of cash flow information:
Cash paid for interest	3,860	5,027	6,330
Cash paid for income taxes	272	223	190
Supplemental disclosure of noncash investing and financing activities:
PPP Loan Forgiveness		4,271
Debt issuance costs	2,760
Financed insurance	1,959
Financed property and equipment	600
Financed inventory		4,015
Purchases of property and equipment in accounts payable	2,128	2,577	3,527
Purchase of intangible assets	750
Recognition of lease liability	1,694	$ 23,403
Modification of lease liability for lease amendment	$ 4,288
Common stock warrants issued with term loan draw			2,974
Common stock issued for partial extinguishment of debt			$ 33,807